(current Good Manufacturing Processes) The guidelines to insure the safety, purity and effectiveness of manufactured pharmaceuticals. The FDA is responsible for the enforcement of these guidelines
Regulations that describe the methods, equipment, facilities, and controls for producing human pharmaceutical products, veterinary products, and biologically derived products. Go to http://www.cgmp.com/overview.htm to find out more.
Current Good Manufacturing Practice, formal standards of facilities’ cleanliness, process, quality controls and documentation set out and periodically monitored by the main medicines control agencies to which a company has to conform in order to manufacture a medicinal product for human use
Current Good Manufacturing Practices - Government promulgated guidelines governing the manufacture of human and animal drugs and biologicals.
Clinical Good Manufacturing Practices are standard guidelines set out by the FDA to ensure drug development is carried out in safe and quality processes, to avoid contamination and ensure repeatability.
cGMP (current good manufacturing practice) is the mandatory certification for production plants that serve the pharmaceutical industry.
Manufacturing practices for drugs as set out in the regulations of the United States, Canada, and other countries.
Current Good Manufacturing Practice: the basis principles, procedures and resources required to ensure an environment suitable for manufacturing products of an acceptable quality.
Current accepted standards of operation in a regulated industry. The FDA is empowered to inspect drug manufacturing plants in which drugs are processed, manufactured, packaged and stored for compliance with these standards.